Good Manufacturing Practice (GMP)

Good Manufacturing Practice (GMP) encompasses comprehensive regulations and quality standards governing pharmaceutical manufacturing, ensuring products are consistently produced and controlled according to quality standards appropriate to their intended use. These extensive requirements address all manufacturing aspects including facilities, equipment, personnel, materials, production processes, quality control, documentation, and distribution, creating systems that prevent contamination, mix-ups, and errors.

The biopharmaceutical industry implements sophisticated GMP programmes supporting manufacturing operations from clinical trial materials through commercial production. Facility design incorporates appropriate environmental controls including HVAC systems, cleanrooms, airlocks, and segregated areas preventing cross-contamination. Equipment qualification programmes demonstrate suitability through installation, operational, and performance qualification studies. Quality control performs testing verifying products meet specifications before release. Change control systems evaluate proposed modifications ensuring product quality is not adversely affected. Validation programmes demonstrate processes consistently produce acceptable products. As manufacturing evolves through continuous processing, single-use technologies, and digitalisation, GMP frameworks adapt incorporating innovation while maintaining quality principles ensuring every manufactured dose meets standards protecting patient safety.